4.5 Article

Comparison of Pandemic and Seasonal Influenza in the Pediatric Emergency Department

Journal

PEDIATRIC INFECTIOUS DISEASE JOURNAL
Volume 30, Issue 8, Pages 633-639

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/INF.0b013e3182103d54

Keywords

pediatrics; pandemic A/H1N1 influenza; emergency hospital services; hospitalization; clinical manifestations

Ask authors/readers for more resources

Background: Emergency department (ED) presentation of pediatric pandemic H1N1 (pH1N1) infection is not well characterized. Our objective was to describe the clinical manifestations of pH1N1 in the pediatric ED. We also compared these characteristics to seasonal influenza A, and explored risk factors for pH1N1 hospitalization. Methods: We conducted a retrospective cohort study at a pediatric hospital in Quebec City, Canada. Subjects were ED patients aged 0 to 17 years with laboratory-confirmed pH1N1 (April-July 2009) or seasonal influenza A (June 2006-March 2009). Clinical and laboratory data were analyzed by univariate and multivariate log-binomial regression. Results: A total of 127 pH1N1 cases and 110 seasonal influenza cases were identified. pH1N1 patients were older (9.5 vs. 5.6 years; P < 0.0001) and presented more rapidly (2.8 vs. 3.5 days; P = 0.02). Clinical manifestations were similar, although gastrointestinal findings were less frequent in pH1N1 (relative risk [RR]: 0.49; 95% confidence interval [CI]: 0.37-0.65). Hospitalization risk was similar (RR: 1.12; 95% CI: 0.81-1.55), but hospitalized pH1N1 subjects were more frequently diagnosed with pneumonia (RR: 2.41; 95% CI: 1.16-5.00). In a multivariable model, age < 2 years was independently associated with pH1N1 hospitalization (RR: 3.17; 95% CI: 1.78-5.65), whereas the absence of significant comorbidities decreased its risk (RR: 0.51; 95% CI: 0.31-0.85). Conclusions: After adjustment for age and delay to presentation, clinical manifestations and 21-day outcomes of pediatric pH1N1 were similar to those of seasonal influenza. pH1N1 patients with previously established risk factors for severe seasonal influenza experienced increased hospitalization risk. Our results suggest that pH1N1 clinical diagnosis and management in the pediatric ED can be performed in a manner similar to seasonal influenza.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series

Florence Cote, Guy Boivin, Vilayvong Loungnarath, Annie Ruest, Julie Bestman-Smith, Julie Carbonneau, Marie-Eve Hamelin, Marie-Claude Roy

Summary: This study describes 10 COVID-19 patients with severe symptoms who were treated with tocilizumab and dexamethasone. The duration of isolation, which exceeded 21 days for 7 patients, was correlated with the Ct values of nucleic acid amplification tests, clinical condition, and viral culture results.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Infectious Diseases

SARS-CoV-2 infection in technology-dependent children: a multicenter case series

Joan Robinson, Tammie Dewan, Shaun K. Morris, Ari Bitnun, Peter Gill, Tala El Tal, Ronald M. Laxer, E. Ann Yeh, Carmen Yea, Rolando Ulloa-Gutierrez, Helena Brenes-Chacon, Adriana Yock-Corrales, Gabriela Ivankovich-Escoto, Alejandra Soriano-Fallas, Marcela Hernandez-de Mezerville, Jesse Papenburg, Marie-Astrid Lefebvre, Alireza Nateghian, Behzad Haghighi Aski, Ali Manafi, Rachel Dwilow, Jared Bullard, Suzette Cooke, Lea Restivo, Alison Lopez, Manish Sadarangani, Ashley Roberts, Nicole Le Saux, Jennifer Bowes, Rupeena Purewal, Janell Lautermilch, Jacqueline K. Wong, Dominique Piche, Karina A. Top, Cheryl Foo, Luc Panetta, Joanna Merckx, Michelle Barton

Summary: This study describes the clinical course and outcomes in children with technology dependence (TD) hospitalized with SARS-CoV-2 infection. The results show that children with TD have an increased risk of COVID-19 hospitalization, but all patients were discharged home in the absence of end-stage chronic conditions.

INFECTION (2023)

Article Clinical Neurology

Neurological involvement in hospitalized children with SARS-CoV-2 infection: a multinational study

Carmen Yea, Michelle Barton, Ari Bitnun, Shaun K. Morris, Tala El Tal, Rolando Ulloa-Gutierrez, Helena Brenes-Chacon, Adriana Yock-Corrales, Gabriela Ivankovich-Escoto, Alejandra Soriano-Fallas, Marcela Hernandez-de Mezerville, Peter Gill, Alireza Nateghian, Behzad Haghighi Aski, Ali Anari Manafi, Rachel Dwilow, Jared Bullard, Jesse Papenburg, Rosie Scuccimarri, Marie-Astrid Lefebvre, Suzette Cooke, Tammie Dewan, Lea Restivo, Alison Lopez, Manish Sadarangani, Ashley Roberts, Jacqueline Wong, Nicole Le Saux, Jennifer Bowes, Rupeena Purewal, Janell Lautermilch, Cheryl Foo, Joanna Merckx, Joan Robinson, E. Ann Yeh

Summary: This multicenter observational study aimed to describe the characteristics and prevalence of neurological involvement in hospitalized pediatric patients with SARS-CoV-2. The results showed that approximately 21% of hospitalized children had neurological signs/symptoms, with headache, encephalopathy, and seizures being the most reported. Factors associated with neurological involvement included ICU admission, satisfaction of MIS-C criteria, fever during hospitalization, and gastrointestinal involvement.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Editorial Material Medicine, General & Internal

Parechovirus infections in infants

Maude Paquette, Christian Renaud, Jesse Papenburg

CANADIAN MEDICAL ASSOCIATION JOURNAL (2023)

Article Immunology

Nosocomial RSV-related In-hospital Mortality in Children <5 Years: A Global Case Series

Yvette N. N. Lowensteyn, Joukje E. E. Willemsen, Natalie I. I. Mazur, Nienke M. M. Scheltema, Nynke C. J. van Haastregt, Amber A. A. ten Buuren, Ichelle van Roessel, Dunja Scheepmaker, Harish Nair, Peter M. M. van de Ven, Louis J. J. Bont

Summary: This study provides the first global case series of children dying with nosocomial RSV infection. Infant-targeted immunization strategies in the future could prevent the majority of nosocomial RSV-related deaths. Although nosocomial RSV deaths are expected to occur at highest rates in low- and lower-middle-income countries (LMICs), the reported number of these deaths was low in these countries. Hospital-based surveillance is needed to capture the full burden of nosocomial RSV mortality in LMICs.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Article Pediatrics

Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager

Aidan Pucchio, Maya Heled Akiva, Helena Evangeliou, Jesse Papenburg, Marina Salvadori

Summary: This article presents a pediatric case of severe rhabdomyolysis following COVID-19 mRNA vaccination. The patient experienced muscle pain and dark urine after vaccination, and was diagnosed with rhabdomyolysis. With treatment, the patient recovered well.

PEDIATRIC NEPHROLOGY (2023)

Letter Pediatrics

Response to Finsterer and Scorza

Marina I. Salvadori, Aidan Pucchio, Maya Heled Akiva, Helena Evangeliou, Jesse Papenburg

PEDIATRIC NEPHROLOGY (2023)

Editorial Material Medicine, General & Internal

Parechovirus infections in infants

Maude Paquette, Christian Renaud, Jesse Papenburg

CANADIAN MEDICAL ASSOCIATION JOURNAL (2023)

Article Infectious Diseases

Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada

Kate Zinszer, Katia Charland, Laura Pierce, Adrien Saucier, Britt McKinnon, Marie-eve Hamelin, Islem Cheriet, Margot Barbosa Da Torre, Julie Carbonneau, Cat Tuong Nguyen, Gaston De Serres, Jesse Papenburg, Guy Boivin, Caroline Quach

Summary: This study aimed to assess the seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies in children and adolescents in Montreal, Canada. The results showed an increasing trend in infection rates among children during the study period, with higher rates observed in females, racial or ethnic minorities, and low-income households. The likelihood of remaining seropositive at 6 months and 1 year after infection was 68% and 42% respectively. Serological studies are important for estimating infection prevalence and understanding the dynamics of antibody levels after infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

Deidre Wilkins, Annefleur C. Langedijk, Robert Jan Lebbink, Christopher Morehouse, Michael E. Abram, Bahar Ahani, Anastasia A. Aksyuk, Eugenio Baraldi, Tyler Brady, Albert Tian Chen, Hsin Chi, Eun Hwa Choi, Robert Cohen, Daria M. Danilenko, Vancheswaran Gopalakrishnan, Anne Greenough, Terho Heikkinen, Mitsuaki Hosoya, Christian Keller, Elizabeth J. Kelly, Leyla Kragten-Tabatabaie, Federico Martinon-Torres, Abiel Homero Mascarenas de los Santos, Marta C. Nunes, Maria Angelica Palomino, Jesse Papenburg, Jeffrey M. Pernica, Peter Richmond, Renato Stein, Kevin M. Tuffy, Charl Verwey, Mark T. Esser, David E. Tabor, Louis J. Bont, INFORM RSV Study Grp

Summary: This study evaluated the geotemporal distribution of RSV A and RSV B between 2015 and 2021 and functionally characterized the nirsevimab binding-site substitutions during this period. The results showed that the nirsevimab binding site remained highly conserved, with only a few rare mutations affecting nirsevimab neutralization emerging between 2016 and 2021. The genetic diversity of RSV fusion protein was lower compared to influenza hemagglutinin and SARS-CoV-2 spike proteins.

LANCET INFECTIOUS DISEASES (2023)

Letter Medicine, General & Internal

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants

William J. Muller, Shabir A. Madhi, Beatriz Seoane Nunez, Manuel Baca Cots, Miroslava Bosheva, Ron Dagan, Laura L. Hammitt, Conrado J. Llapur, Jose M. Novoa, Xavier Saez Llorens, Amy Grenham, Elizabeth J. Kelly, Vaishali S. Mankad, Manish Shroff, Therese Takas, Amanda Leach, Tonya Villafana

Summary: Nirsevimab, a monoclonal antibody, effectively prevents hospitalization and severe lower respiratory tract infection in term and late-preterm infants caused by respiratory syncytial virus (RSV).

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Medicine, General & Internal

Occupation and SARS-CoV-2 seroprevalence studies: a systematic review

Emily Boucher, Christian Cao, Sean D'Mello, Nathan Duarte, Claire Donnici, Natalie Duarte, Graham Bennett, Anil SeroTracker Consortium, Anil Adisesh, Rahul Arora, David Kodama, Niklas Bobrovitz

Summary: This study synthesised and described SARS-CoV-2 seroprevalence studies by occupation before the widespread vaccine roll-out. The results showed significant differences in seroprevalence between occupations, but most studies had small sample sizes and high risk of bias. More high-quality studies are needed to improve our understanding of the occupational risk of SARS-CoV-2.

BMJ OPEN (2023)

Article Public, Environmental & Occupational Health

The effect of Telehealth Antimicrobial Stewardship Program (Tele-ASP) on antimicrobial use in a pediatric intensive care unit: Pre- and post-implementation single center study

Abdulla Alfraij, Ahmed Abdelmoniem, Mohamed Elseadawy, Mohammad Surour, Mohamed Basuni, Jesse Papenburg, Mohammad Alghounaim

Summary: This study aimed to evaluate the impact of telehealth antimicrobial stewardship program (ASP) on the rate of antimicrobial use in pediatric intensive care units (PICU), and found that it significantly decreased antimicrobial use.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2023)

Article Microbiology

Viral Fitness of Baloxavir-Resistant Recombinant Influenza B/Victoria- and B/Yamagata-like Viruses Harboring the I38T PA Change, In Vitro, Ex Vivo and in Guinea Pigs

Amel Saim-Mamoun, Julie Carbonneau, Chantal Rheaume, Yacine Abed, Guy Boivin

Summary: Baloxavir, the latest antiviral drug approved against seasonal influenza A and B viruses, shows low resistance against the PA-I38T substitution. This study evaluates the impact of this substitution on the fitness of contemporary influenza B viruses. The results indicate that influenza B viruses with the PA-I38T mutation may retain a significant level of fitness, emphasizing the importance of monitoring the emergence of such variant.

MICROORGANISMS (2023)

Article Infectious Diseases

Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT)

Tilmann Schober, Shaun K. Morris, Julie A. Bettinger, Christina Bancej, Catherine Burton, Cheryl Foo, Scott A. Halperin, Taj Jadavji, Kescha Kazmi, Jacqueline Modler, Manish Sadarangani, Jesse Papenburg

Summary: This study evaluated immunocompromising conditions and subgroups of immunocompromise as risk factors for severe outcomes among children admitted for influenza. The results showed that immunocompromised children had a decreased risk of ICU admission, mechanical ventilation, and mortality. Therefore, immunocompromised children require special attention and protection.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

No Data Available